Nouveau Life Pharmaceuticals Inc (NOUV)

[Wolverine19]

$NOUV Calculated Fundamental Valuation (0.0361 - 0.1857)

This is the first attempt at calculating a current fundamental valuation for NOUV.

** The Outstanding Shares (OS) according to OTCMarkets is 4,349,999,733 shares.

** Currently, we do not know what the annual revenues for Entuit Inc. is therefore, I will use current revenues from 2 established companies (Honeywell International Inc. & Rockwell Automation Inc.) within this sector and industry.

** Rockwell Automation Inc. annual revenue was $5,879,500 with a P/E Ratio of 25.77
https://finance.yahoo.com/quote/ROK?p=ROK

** Honeywell International Inc. annual revenue was $39,302,000 with a P/E Ratio of 20.63
https://finance.yahoo.com/quote/HON?p=HON

Now consider the current valuation for NOUV from the market formulas that are used for deriving such:

Net Income ÷ Outstanding Shares (OS) = EPS
$5,879,500 Net Income ÷ 4,349,999,733 (OS) = .0014 EPS
$39,302,000 Net Income ÷ 4,349,999,733 (OS) = .0090 EPS

EPS x P/E Ratio = NOUV Share Price Valuation
.0014 EPS x 25.77 P/E Ratio = 0.0361 per share
.0090 EPS x 20.63 P/E Ratio = 0.1857 per share

So currently, NOUV is worth 0.0361 per share on the conservative side and 0.1857 per share on the high end with the current share structure.

These values can change drastically if the company buys back/retire the bulk of the securities. IMO, with Entuit’s Client List of Fortune 500 Companies, Who’s Who of the World Clients, Government Contracts, City Contracts, and many others, Entuit Inc. should fall somewhere in the middle of the two established companies used to derive $NOUV’s Valuation.